Skip to content

Atle Fund Management AB

Follow

13F filer, CIK 1381843, STOCKHOLM, Sweden

Atle Fund Management AB reported $373,391,375 across 39 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-12. Its ten largest share positions make up 53.9% of the portfolio.

Accepted , ingested 13F-HR 0001381843-26-000013

Period
2026-09-30
Reported value
$373M
Holdings
39
Top 10 weight
53.9%
New
4
Sold out
4

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ABBVadded+26,969$7.05M
VRTXadded+9,026$4.72M
TMOadded+6,551$4.42M
INSMadded+29,091$3.32M
SMMTnew+184,687$3.12M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
IONSexited-137,131-$10.9M
NBIXreduced-34,287-$4.86M
BCAXexited-145,657-$4.32M
ALKSreduced-77,104-$3.12M
MRKreduced-20,370-$2.96M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001381843-26-000013, largest first. % of portfolio is the value over $373,391,375, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 37,068 shares; 2025Q1: 34,602 shares; 2025Q2: 38,721 shares; 2025Q3: 37,244 shares; 2025Q4: 31,133 shares; 2026Q1: 39,722 shares; 2026Q2: 29,821 shares; 2026Q3: 31,202 shares 31,202$36.1M9.67%+1,381Timeline
MRKMERCK & CO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 105,727 shares; 2025Q1: 127,679 shares; 2025Q2: 139,172 shares; 2025Q3: 160,913 shares; 2025Q4: 195,768 shares; 2026Q1: 33,853 shares; 2026Q2: 189,357 shares; 2026Q3: 168,987 shares 168,987$24.6M6.58%-20,370Timeline
JNJJOHNSON & JOHNSONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 92,377 shares; 2026Q2: 85,425 shares; 2026Q3: 91,387 shares 91,387$24.2M6.48%+5,962Timeline
ABBVABBVIE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 90,723 shares; 2025Q1: 89,227 shares; 2025Q2: 86,933 shares; 2025Q3: 92,105 shares; 2025Q4: 108,181 shares; 2026Q1: 108,181 shares; 2026Q2: 64,325 shares; 2026Q3: 91,294 shares 91,294$23.9M6.4%+26,969Timeline
TMOTHERMO FISHER SCIENTIFIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 24,896 shares; 2025Q1: 22,857 shares; 2025Q2: 24,266 shares; 2025Q3: 27,147 shares; 2025Q4: 29,915 shares; 2026Q1: 22,986 shares; 2026Q2: 27,859 shares; 2026Q3: 34,410 shares 34,410$23.2M6.22%+6,551Timeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 62,781 shares; 2026Q3: 70,955 shares 70,955$16M4.29%+8,174Timeline
VRTXVERTEX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 22,257 shares; 2025Q1: 22,808 shares; 2025Q2: 24,328 shares; 2025Q3: 17,766 shares; 2025Q4: 22,984 shares; 2026Q1: 22,984 shares; 2026Q2: 19,131 shares; 2026Q3: 28,157 shares 28,157$14.7M3.94%+9,026Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 62,161 shares; 2025Q1: 54,961 shares; 2025Q2: 82,275 shares; 2025Q3: 85,355 shares; 2025Q4: 90,184 shares; 2026Q1: 617,245 shares; 2026Q2: 73,077 shares; 2026Q3: 66,113 shares 66,113$13.6M3.63%-6,964Timeline
ONCBEONE MEDICINES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,900 shares; 2025Q1: 25,141 shares; 2025Q2: 24,386 shares; 2025Q3: 30,333 shares; 2025Q4: 40,432 shares; 2026Q1: 41,717 shares; 2026Q2: 35,180 shares; 2026Q3: 35,679 shares 35,679$13.1M3.5%+499Timeline
CVSCVS HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 106,518 shares; 2026Q1: 23,773 shares; 2026Q2: 146,102 shares; 2026Q3: 139,311 shares 139,311$11.9M3.2%-6,791Timeline
CORCENCORA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 32,553 shares; 2025Q1: 31,553 shares; 2025Q2: 31,466 shares; 2025Q3: 28,608 shares; 2025Q4: 23,773 shares; 2026Q1: 23,470 shares; 2026Q2: 31,126 shares; 2026Q3: 36,107 shares 36,107$10.8M2.9%+4,981Timeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 103,032 shares; 2025Q1: 151,348 shares; 2025Q2: 165,480 shares; 2025Q3: 174,722 shares; 2025Q4: 141,296 shares; 2026Q1: 111,363 shares; 2026Q2: 124,707 shares; 2026Q3: 163,697 shares 163,697$10.8M2.88%+38,990Timeline
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 15,345 shares; 2025Q2: 18,559 shares; 2025Q3: 19,707 shares; 2025Q4: 22,322 shares; 2026Q1: 70,851 shares; 2026Q2: 24,656 shares; 2026Q3: 25,648 shares 25,648$10.4M2.79%+992Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 27,873 shares; 2026Q1: 97,438 shares; 2026Q2: 58,378 shares; 2026Q3: 87,469 shares 87,469$9.98M2.67%+29,091Timeline
EWEDWARDS LIFESCIENCES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 68,296 shares; 2025Q1: 59,696 shares; 2025Q2: 57,360 shares; 2025Q3: 65,659 shares; 2025Q4: not reported; 2026Q1: 106,518 shares; 2026Q2: 103,230 shares; 2026Q3: 109,647 shares 109,647$9.46M2.53%+6,417Timeline
SYKSTRYKER CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 25,660 shares; 2025Q1: 22,998 shares; 2025Q2: 27,466 shares; 2025Q3: 22,769 shares; 2025Q4: 26,835 shares; 2026Q1: 26,835 shares; 2026Q2: 30,283 shares; 2026Q3: 34,296 shares 34,296$9.44M2.53%+4,013Timeline
INCYINCYTE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 70,851 shares; 2026Q1: 50,796 shares; 2026Q2: 56,953 shares; 2026Q3: 77,377 shares 77,377$9.39M2.51%+20,424Timeline
KRYSKRYSTAL BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 9,202 shares; 2025Q1: 23,491 shares; 2025Q2: 20,158 shares; 2025Q3: 42,191 shares; 2025Q4: 33,853 shares; 2026Q1: 37,579 shares; 2026Q2: 24,019 shares; 2026Q3: 28,074 shares 28,074$9.34M2.5%+4,055Timeline
DXCMDEXCOM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 60,057 shares; 2025Q1: 45,841 shares; 2025Q2: 50,872 shares; 2025Q3: 50,872 shares; 2025Q4: 39,722 shares; 2026Q1: 584,332 shares; 2026Q2: 71,846 shares; 2026Q3: 89,251 shares 89,251$7.7M2.06%+17,405Timeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 138,983 shares; 2025Q1: 107,783 shares; 2025Q2: 157,223 shares; 2025Q3: 193,625 shares; 2025Q4: 197,036 shares; 2026Q1: 94,796 shares; 2026Q2: 248,848 shares; 2026Q3: 303,824 shares 303,824$7.39M1.98%+54,976Timeline
IRTCIRHYTHM HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 20,547 shares; 2025Q2: 25,302 shares; 2025Q3: 29,991 shares; 2025Q4: 37,579 shares; 2026Q1: 22,322 shares; 2026Q2: 54,102 shares; 2026Q3: 54,102 shares 54,102$6.15M1.65%0Timeline
GILDGILEAD SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 76,998 shares; 2025Q2: 73,165 shares; 2025Q3: 78,169 shares; 2025Q4: 50,796 shares; 2026Q1: 47,967 shares; 2026Q2: 46,142 shares; 2026Q3: 40,461 shares 40,461$6.03M1.62%-5,681Timeline
MIRMMIRUM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 116,692 shares; 2025Q1: 77,263 shares; 2025Q2: 106,912 shares; 2025Q3: 93,605 shares; 2025Q4: 89,685 shares; 2026Q1: 195,768 shares; 2026Q2: 100,807 shares; 2026Q3: 70,071 shares 70,071$5.99M1.6%-30,736Timeline
CAHCARDINAL HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 30,680 shares; 2025Q1: 27,688 shares; 2025Q2: 26,797 shares; 2025Q3: 30,297 shares; 2025Q4: 23,470 shares; 2026Q1: 108,682 shares; 2026Q2: 23,630 shares; 2026Q3: 26,735 shares 26,735$5.95M1.59%+3,105Timeline
BSXBOSTON SCIENTIFIC CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 154,222 shares; 2025Q1: 132,273 shares; 2025Q2: 126,185 shares; 2025Q3: 86,680 shares; 2025Q4: 108,682 shares; 2026Q1: 40,432 shares; 2026Q2: 146,381 shares; 2026Q3: 130,622 shares 130,622$5.7M1.53%-15,759Timeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 266,499 shares; 2025Q1: 214,778 shares; 2025Q2: 227,224 shares; 2025Q3: 252,875 shares; 2025Q4: 242,473 shares; 2026Q1: 242,473 shares; 2026Q2: 213,329 shares; 2026Q3: 136,225 shares 136,225$5.52M1.48%-77,104Timeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 67,763 shares; 2025Q1: 75,881 shares; 2025Q2: 88,392 shares; 2025Q3: 102,625 shares; 2025Q4: 94,796 shares; 2026Q1: 89,685 shares; 2026Q2: 72,898 shares; 2026Q3: 38,611 shares 38,611$5.48M1.47%-34,287Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 29,915 shares; 2026Q2: 198,557 shares; 2026Q3: 184,394 shares 184,394$4.6M1.23%-14,163Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 31,590 shares; 2026Q1: 31,590 shares; 2026Q2: 58,170 shares; 2026Q3: 46,452 shares 46,452$4.6M1.23%-11,718Timeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 62,735 shares; 2026Q2: 57,030 shares; 2026Q3: 44,243 shares 44,243$3.94M1.05%-12,787Timeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 54,886 shares; 2026Q3: 43,180 shares 43,180$3.6M0.96%-11,706Timeline
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 97,438 shares; 2026Q1: 31,133 shares; 2026Q2: 94,478 shares; 2026Q3: 93,550 shares 93,550$3.59M0.96%-928Timeline
SMMTSUMMIT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 101,177 shares; 2025Q1: 105,077 shares; 2025Q2: 92,737 shares; 2025Q3: 92,737 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 184,687 shares 184,687$3.12M0.84%newTimeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 243,506 shares 243,506$3.03M0.81%newTimeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 24,652 shares; 2025Q3: 45,690 shares; 2025Q4: 47,967 shares; 2026Q1: 107,255 shares; 2026Q2: 43,682 shares; 2026Q3: 43,682 shares 43,682$2.86M0.77%0Timeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 37,157 shares; 2025Q4: 41,831 shares; 2026Q1: 141,296 shares; 2026Q2: 33,313 shares; 2026Q3: 29,893 shares 29,893$2.38M0.64%-3,420Timeline
PVLAPALVELLA THERAPEUTICS INC NEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 14,924 shares 14,924$2.06M0.55%newTimeline
PYXSPYXIS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 617,245 shares; 2026Q1: 197,036 shares; 2026Q2: 966,459 shares; 2026Q3: 663,772 shares 663,772$1.55M0.41%-302,687Timeline
MANEVERADERMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 10,106 shares 10,106$1.23M0.33%newTimeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
IONSIONIS PHARMACEUTICALS INC137,131$10.9Mshares
BCAXBICARA THERAPEUTICS INC145,657$4.32Mshares
CMPXCOMPASS THERAPEUTICS INC1,048,593$2.3Mshares
JBIOJADE BIOSCIENCES INC88,556$1.97Mshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001381843-26-000013 base2026-11-12